Webb28 mars 2024 · The estimated net worth of Christopher D. Alafi is at least $16.31 million as of May 27th, 2024. Dr. Alafi owns 346,795 shares of Intra-Cellular Therapies stock worth more than $16,309,769 as of February 24th. This net worth estimate does not reflect any other investments that Dr. Alafi may own. Learn More about Christopher D. Alafi's net … WebbStudy Objective. Approved treatments for bipolar depression are limited and associated with a spectrum of undesirable side effects. Lumateperone (lumateperone tosylate, ITI−007), a mechanistically novel antipsychotic that simultaneously modulates serotonin, dopamine, and glutamate neurotransmission, is FDA-approved for the treatment of …
SHARON MATES, PART OF THE FORMULA AT NORTH AMERICAN …
Webb28 maj 2024 · The estimated Net Worth of Christopher D Alafi is at least $8.89 Million dollars as of 27 May 2024. Christopher Alafi owns over 47,325 units of Intra-Cellular Therapies Inc stock worth over $5,633,500 and over the last 9 years he sold ITCI stock worth over $3,017,186. In addition, he makes $240,737 as Independent Director at Intra … WebbSharon Mates, Ph.D. Founder, Chairman & Chief Executive Officer Read More Suresh Durgam, M.D. Executive Vice President, Chief Medical Officer Read More Mark Neumann … in what year nail painting came back in vogue
Sharon Mates, Ph.D NewYorkBIO
Webbför 12 timmar sedan · 561. Free-Float. 96,8%. More Financials. Company. Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological … Webb26 apr. 2024 · The company was founded by Paul Greengard and Sharon Mates in 2002 and is headquartered in New York, NY. Show more Ideas ITCI potential breakout trade ITCI is a biotech setting up for a potential breakout at the $60 level. The biotech sector is showing market-leading strength off the lows with many stocks in this group at or … WebbSharon Mates has been the Chairman of the board of directors, President and Chief Executive Officer of ITI since June 2002. Dr. Mates co-founded ITI in May 2002. Prior to … onmtf